Tarn Tran police have busted a cross-border, ISI-controlled-Pakistan based narco-smuggling module operated by UK-based drug ...

NEW YORK and MELBOURNE, Australia, May 15, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex), a clinical-stage biopharmaceutical company leading the way in developing oral ...

Thirty-five fixed-dose combinations prohibited due to non-compliance with safety standards * Public safety threatened by drug ...

Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic ...

Phase 1 clinical trial to evaluate the pharmacokinetics (PK) of a combination of denifanstat and resmetirom expected to ...

Millions of older adults take five or more prescription drugs every day to manage chronic illnesses. While polypharmacy is ...

Lantern Pharma's LP-184 advances to Phase 1b/2 trial in TNBC after FDA clearance, adding to its Fast Track and Rare Pediatric Disease designations.

SHANGHAI, April 30, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, presented 6 study results of innovative drugs and platforms in ...

Abstract: Synergistic drug combinations have shown promising results in treating cancer cell lines by enhancing therapeutic efficacy and minimizing adverse reactions. The effects of a drug vary across ...

A week after the Centre restricted the use of fixed-dose combination (FDC) common cold drugs in children below four years of age, the Delhi High Court held on Thursday that the restriction will apply ...